• SELECT SITE CURRENCY
Select a currency for use throughout the site
Global Bioinformatics Market Outlook
RNCOS E-Services Private Limited, March 2011, Pages: 70
Major countries of the world have always tried to build strategies that ensure better development of strong biotechnology sector and in this aim; bio-informatics has been playing a vital role. Governments, leading associations, and market players are actively participating in creating an environment that facilitates bio-informatics research and boost intellectual and entrepreneur expertise. Despite recession, implementation & development of computational tools and frameworks for the management, analysis and interpretation of biological information remained the focal point of leading industrial players.
As per our new research report “Global Bioinformatics Market Outlook”, the market for bioinformatics will surge at a CAGR of nearly 26% during 2011-2013 to reach a value of around US$ 6.2 Billion by 2013. A host of developments are taking place in genomics and molecular research that are likely to boost the bioinformatics industry. Moreover, significant advances in the field of proteomics and related technologies are being observed and may influence the way research and diagnostic analysis are and performed. With the increasing R&D investments by various companies and the government support, we anticipate that the bioinformatics market will post higher growth rate in most of the countries.
Bioinformatics play a vital role in supporting and strengthening several application areas, which include genomics, proteomics, pharmacogenomics, and cheminformatics. Our report covers these areas also and defines their market size along with their future projections. Other research areas of bioinformatics, like oncology are also highlighted in the report.
“Global Bioinformatics Market Outlook” is an outcome of an in-depth research and rational analysis of the global bioinformatics market and key active market players. It investigates the current market trends in key countries and provides a knowhow on key market drivers, which will provide clients with information that will facilitate them in taking prudent investment decisions. The report also includes statistical analysis of different segments along with technological trends to present a comprehensive overview of the market.
1. Analyst View
2. Key Industry Trends
2.1 Increasing R&D Investment
2.2 Strategic Collaboration
2.3 Regulatory Support
2.4 Research on Oncology
3. Market Overview
3.1 By Segment
3.1.1 Analysis Software & Services Market
3.1.2 Content Market
3.1.3 IT Infrastructure & Other Services Market
3.2 By Application
3.2.4 Drug Discovery
4. Prominent Country Profile
4.6 South Korea
5. Key Market Drivers
5.1 IT & Internet Growth
5.2 Enhanced Drug Development Process
5.3 Dwindling Drug Pipelines & Patent Expirations
5.4 Efficient Storage & Analysis of Research Data
6. Key Players
6.1 Accelrys, Inc.
6.2 Affymetrix, Inc.
6.3 Celera Genomics Group
6.4 Compugen Ltd.
6.5 IBM Life Sciences
List of Tables:
Table 3-1: Top Countries for High Content Analysis Research
Table 3-2: Growth in Key Bioinformatics Databases (Dec 2004 & Dec 2005)
Table 3-3: Top Countries for DNA Sequence Analysis Research
Table 3-4: Top Countries for Proteomics Research
Table 4-1: Top Countries for Bioinformatics Research
List of Figures:
Figure 3-1: Global - Bioinformatics Market (Billion US$), 2009-2013
Figure 3-2: Global - Bioinformatics Market by Region (%), 2009
Figure 3-3: Global - Bioinformatics Market by Segment (%), 2010
Figure 3-4: Global - Analysis Software & Services Market (Million US$), 2007-2010
Figure 3-5: Global - Content Market (Million US$), 2007-2010
Figure 3-6: Global - IT Infrastructure & Other Services Market (Million US$), 2007-2010
Figure 3-7: Global - DNA Sequencing Market (Billion US$), 2009-2013
Figure 3-8: Global - Proteomics Market (Billion US$), 2009-2013
Figure 3-9: Global - Pharmacogenomics Market by Core Segment (%), 2009
Figure 4-1: UK - Bioinformatics Market (Million US$), 2009-2013
Figure 4-2: Japan - Bioinformatics Market (Billion Yen), 2007-2010
Figure 4-3: India - Bioinformatics Market (Billion `), 2007-08 to 2012-13
Figure 4-4: South Korea - Bioinformatics Market (Million US$), 2009-2013
Figure 5-1: Global - Number of Drugs Facing Patent Expirations (2008-2011)
Figure 5-2: Global - Loss due to Drug Patent Expirations (Billion US$), 2008-2011
- Accelrys, Inc.
- Affymetrix, Inc.
- Celera Genomics Group
- Compugen Ltd.
- IBM Life Sciences
A sample for this product is available. Please Login/Register to download this sample.